secwatch.observer — SEC 8-K summary
======================================

Issuer:     STANDARD BIOTOOLS INC. (LAB)
CIK:        0001162194
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001104659-24-095596
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Standard BioTools Adopts 2024 Change of Control and Severance Plan for Key Executives
--------------------------------------------------------------------------------

- Plan provides 12 months base salary and full equity vesting for non-COC termination for COO Kim, CLO Gallagher, CCO Davis, and others.
- For termination during Change of Control Period: 150% lump-sum of base salary plus bonus, 18-month COBRA, and immediate full equity vesting.
- Plan supersedes the 2023 severance plan and covers eight named executives including SVP King, SVP Abou-Sayed, and CHRO Jensen.
- Plan term runs until August 4, 2026; CEO Michael Egholm remains covered under separate 2023 plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1162194/000110465924095596/0001104659-24-095596-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1162194/000110465924095596/tm2422827d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-095596

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer